Oehler VG, Berman E, Huang IJ. Management of chronic myeloid leukemia with tyrosine kinase inhibitors: adverse events, toxicities and therapy dosing. haematol [Internet]. 2026Jul.1 [cited 2026Jul.17];111(7):2266-80. Available from: https://haematologica.org/article/view/13384